Nevimune Tablets

Mili Healthcare
  • Category :
  • Manufacturer : Cipla Ltd.
  • Description : NEVIMUNE Tablets : ................. Contains blister of 10 tablets Additional important information regarding the use of nevirapine for the treatment of HIV-1 infection is given below Based on serious and life-threatening hepatotoxicity observed in controlled and uncontrolled studies, NEVIMUNE should not be initiated in adult females with CD4+ cell counts greater than 250 cells/mm 3 or in adult males with CD4+ cell counts greater than 400 cells/mm 3 unless the benefit outweighs the risk
  • Indication : NEVIMUNE is indicated for use in combination with other antiretroviral agents for the treatment of HIV-1 infection.
  • Strength : 200 mg
  • The content presented on the MILI HEALTHCARE website is presented solely for informational purposes.

Cipla Ltd, Glaxo SmithKline (GSK), Ranbaxy, Dr. Reddy's, Zydus Cadila, FDC Ltd, Abbott Laboratories, Johnson & Johnson, Organon, Allergan, Glenmark, German Remedies, Lupin, Serdia, Galderma, Alkem, Alembic, Nicholas Piramal, Martin & Harris, IPCA, RPG Life Sciences, Franco Indian, Wockhardt, Merind.